-
1
Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform
Published 2021-06-01Get full text
Article -
2
Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma
Published 2023-04-01Get full text
Article -
3
-
4
-
5
-
6
The amniotic fluid proteome predicts imminent preterm delivery in asymptomatic women with a short cervix
Published 2022-07-01Get full text
Article -
7
-
8
-
9
The Vaginal Microbiota of Pregnant Women Varies with Gestational Age, Maternal Age, and Parity
Published 2023-08-01Get full text
Article -
10
Differential immunophenotype of circulating monocytes from pregnant women in response to viral ligands
Published 2023-05-01Get full text
Article -
11
-
12
Exhausted and Senescent T Cells at the Maternal-Fetal Interface in Preterm and Term Labor
Published 2019-01-01Get full text
Article -
13
-
14
Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)
Published 2023-06-01“…During the recent outbreak of SUDV virus disease, the Biomedical Advanced Research and Development Authority (BARDA), as part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, implemented key actions with our existing partners to advance preparedness and enable rapid response to the outbreak, while also aligning with global partners involved in the implementation of clinical trials in an outbreak setting. …”
Get full text
Article -
15
-
16
-
17
Impact of Superstorm Sandy on Medicare Patients’ Utilization of Hospitals and Emergency Departments
Published 2017-09-01Get full text
Article -
18
-
19
-
20
Natural History of Marburg Virus Infection to Support Medical Countermeasure Development
Published 2022-10-01“…The Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, recognizes that the evaluation of medical countermeasures under the Animal Rule requires well-characterized and reproducible animal models that are likely to be predictive of clinical benefit. …”
Get full text
Article